Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Jennifer J. Furin, M.D., Ph.D.

Title
Institution
Department
Address
Phone

Mentoring
Evaluating an intervention program addressing the health priorities of women and children in the Carabayllo community of Lima, Peru
International, 10/01/05 - 03/31/06
Scaling-up antiretrovirals in rural Lesotho: Lessons from the field
International, 06/23/06 - 08/18/06
Clinical Elective at McCord Hospital (Durban, South Africa) - spring 2008
International, 03/31/08 - 04/27/08
Chest radiograph findings and tuberculosis diagnosis in HIV infected patients in rural Lesotho
International, 06/16/07 - 08/10/07

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA. Treatment of Multidrug-Resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 Oct; 37(10):1061-1064. PMID: 30216296.
    View in: PubMed
  2. Reuter A, Furin J. Reducing harm in the treatment of multidrug-resistant tuberculosis. Lancet. 2018 Sep 08; 392(10150):797-798. PMID: 30215367.
    View in: PubMed
  3. Seddon JA, Schaaf HS, Marais BJ, McKenna L, Garcia-Prats AJ, Hesseling AC, Hughes J, Howell P, Detjen A, Amanullah F, Singh U, Master I, Perez-Velez CM, Misra N, Becerra MC, Furin JJ. Time to act on injectable-free regimens for children with multidrug-resistant tuberculosis. Lancet Respir Med. 2018 Sep; 6(9):662-664. PMID: 30191832.
    View in: PubMed
  4. Koenig SP, Furin J. Providing quality care on the border with Haiti. Lancet. 2018 08 04; 392(10145):382. PMID: 30102166.
    View in: PubMed
  5. Cruz AT, Garcia-Prats AJ, Furin J, Seddon JA. Treatment of Multidrug-resistant Tuberculosis Infection in Children. Pediatr Infect Dis J. 2018 Aug; 37(8):831-834. PMID: 29742640.
    View in: PubMed
  6. Reuter A, Furin J. Bedaquiline use in South Africa reveals a lifesaving policy in action. Lancet Respir Med. 2018 Sep; 6(9):653-655. PMID: 30001995.
    View in: PubMed
  7. Harausz EP, Garcia-Prats AJ, Law S, Schaaf HS, Kredo T, Seddon JA, Menzies D, Turkova A, Achar J, Amanullah F, Barry P, Becerra M, Chan ED, Chan PC, Ioana Chiotan D, Crossa A, Drobac PC, Fairlie L, Falzon D, Flood J, Gegia M, Hicks RM, Isaakidis P, Kadri SM, Kampmann B, Madhi SA, Marais E, Mariandyshev A, Méndez-Echevarría A, Moore BK, Nargiza P, Ozere I, Padayatchi N, Ur-Rehman S, Rybak N, Santiago-Garcia B, Shah NS, Sharma S, Shim TS, Skrahina A, Soriano-Arandes A, van den Boom M, van der Werf MJ, van der Werf TS, Williams B, Yablokova E, Yim JJ, Furin J, Hesseling AC. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis. PLoS Med. 2018 Jul; 15(7):e1002591. PMID: 29995958.
    View in: PubMed
  8. Mohr E, Hughes J, Reuter A, Trivino Duran L, Ferlazzo G, Daniels J, De Azevedo V, Kock Y, Steele SJ, Shroufi A, Ade S, Alikhanova N, Benedetti G, Edwards J, Cox H, Furin J, Isaakidis P. Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa. Eur Respir J. 2018 Jun; 51(6). PMID: 29724920.
    View in: PubMed
  9. Cox V, Brigden G, Crespo RH, Lessem E, Lynch S, Rich ML, Waning B, Furin J. Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2018 Apr 01; 22(4):407-412. PMID: 29562988.
    View in: PubMed
  10. Dheda K, Gumbo T, Lange C, Horsburgh CR, Furin J. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 04; 6(4):240-242. PMID: 29595502.
    View in: PubMed
  11. Furin J, Tommasi M, Garcia-Prats AJ. Drug-resistant tuberculosis: will grand promises fail children and adolescents? Lancet Child Adolesc Health. 2018 Apr; 2(4):237-238. PMID: 30169295.
    View in: PubMed
  12. Ferlazzo G, Mohr E, Laxmeshwar C, Hewison C, Hughes J, Jonckheere S, Khachatryan N, De Avezedo V, Egazaryan L, Shroufi A, Kalon S, Cox H, Furin J, Isaakidis P. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Lancet Infect Dis. 2018 May; 18(5):536-544. PMID: 29452942.
    View in: PubMed
  13. Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA. Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis". Antimicrob Agents Chemother. 2018 Jan; 62(1). PMID: 29269434.
    View in: PubMed
  14. Cox V, Furin J. World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied? Int J Tuberc Lung Dis. 2017 12 01; 21(12):1211-1213. PMID: 29297439.
    View in: PubMed
  15. Miller-Fellows SC, Howard L, Kramer R, Hildebrand V, Furin J, Mutuku FM, Mukoko D, Ivy JA, King CH. Cross-sectional interview study of fertility, pregnancy, and urogenital schistosomiasis in coastal Kenya: Documented treatment in childhood is associated with reduced odds of subfertility among adult women. PLoS Negl Trop Dis. 2017 Nov; 11(11):e0006101. PMID: 29176778.
    View in: PubMed
  16. Furin J, Lessem E, Cox V. Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis. Eur Respir J. 2017 Nov; 50(5). PMID: 29122918.
    View in: PubMed
  17. Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J. The devil we know: is the use of injectable agents for the treatment of MDR-TB justified? Int J Tuberc Lung Dis. 2017 11 01; 21(11):1114-1126. PMID: 29037291.
    View in: PubMed
  18. Mohr E, Daniels J, Muller O, Furin J, Chabalala B, Steele SJ, Cox V, Dolby T, Ferlazzo G, Shroufi A, Duran LT, Cox H. Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1100-1105. PMID: 28911352.
    View in: PubMed
  19. Furin J, Cox H. To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis. Clin Infect Dis. 2017 Oct 01; 65(7):1212-1213. PMID: 28549086.
    View in: PubMed
  20. Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA. Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2017 Oct; 61(10). PMID: 28739794.
    View in: PubMed
  21. Vambe D, Dlamini T, Furin J, Gracia-Edwards C, Keus K, Kunene K, Shabangu A, Dlamini SN, Sikhondze W. Operational aspects of bedaquiline implementation in Swaziland: report from the field. Public Health Action. 2017 Sep 21; 7(3):240-242. PMID: 29201660.
    View in: PubMed
  22. Lessem E, Cox V, Furin J. Bedaquiline or delamanid for rifampin-resistant tuberculosis? Lancet Respir Med. 2017 10; 5(10):772-774. PMID: 28887015.
    View in: PubMed
  23. Cox H, Reuter A, Furin J, Seddon J. Prevention of hearing loss in patients with multidrug-resistant tuberculosis. Lancet. 2017 09 02; 390(10098):934. PMID: 28872029.
    View in: PubMed
  24. Harausz EP, Leigh J, Garcia-Prats AJ, Furin J, Peloquin CA. Stability of Second-Line Tuberculosis Medications Mixed With Milk or Yogurt. Clin Infect Dis. 2017 Aug 15; 65(4):704-705. PMID: 28482036.
    View in: PubMed
  25. Kunkel A, Furin J, Cohen T. Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified? Lancet Infect Dis. 2017 Dec; 17(12):e429-e433. PMID: 28533094.
    View in: PubMed
  26. Harausz EP, Garcia-Prats AJ, Seddon JA, Schaaf HS, Hesseling AC, Achar J, Bernheimer J, Cruz AT, D'Ambrosio L, Detjen A, Graham SM, Hughes J, Jonckheere S, Marais BJ, Migliori GB, McKenna L, Skrahina A, Tadolini M, Wilson P, Furin J. New and Repurposed Drugs for Pediatric Multidrug-Resistant Tuberculosis. Practice-based Recommendations. Am J Respir Crit Care Med. 2017 05 15; 195(10):1300-1310. PMID: 27854508.
    View in: PubMed
  27. Pai M, Furin J. Tuberculosis innovations mean little if they cannot save lives. Elife. 2017 05 02; 6. PMID: 28460659.
    View in: PubMed
  28. Jonckheree S, Furin J. Overcoming challenges in the diagnosis, prevention, and treatment of pediatric drug-resistant tuberculosis. Expert Rev Respir Med. 2017 05; 11(5):385-394. PMID: 28319425.
    View in: PubMed
  29. Weld ED, Garcia-Prats AJ, Furin JJ, Bailey TC, Hesseling AC, Dooley KE. The time has come: sparing injectables in paediatric MDR-TB. Lancet Respir Med. 2017 Mar 15. PMID: 28344008.
    View in: PubMed
  30. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017 Mar 15. PMID: 28344011.
    View in: PubMed
  31. Guglielmetti L, Hewison C, Avaliani Z, Hughes J, Kiria N, Lomtadze N, Ndjeka N, Setkina S, Shabangu A, Sikhondze W, Skrahina A, Veziris N, Furin J. Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries. Int J Tuberc Lung Dis. 2017 02 01; 21(2):167-174. PMID: 28234080.
    View in: PubMed
  32. Furin J, Diacon AH, Andries K. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline. Int J Tuberc Lung Dis. 2017 01 01; 21(1):4-5. PMID: 28157457.
    View in: PubMed
  33. Furin J, Isaakidis P. Life in the time of antiretrovirals in South Africa. Lancet HIV. 2017 03; 4(3):e95-e96. PMID: 27956186.
    View in: PubMed
  34. Tierney DB, Milstein MB, Manjourides J, Furin JJ, Mitnick CD. Treatment Outcomes for Adolescents With Multidrug-Resistant Tuberculosis in Lima, Peru. Glob Pediatr Health. 2016; 3:2333794X16674382. PMID: 27826599.
    View in: PubMed
  35. Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL. Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2016 11; 60(11):6591-6599. PMID: 27550361.
    View in: PubMed
  36. Dheda K, Chang KC, Guglielmetti L, Furin J, Schaaf HS, Chesov D, Esmail A, Lange C. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Microbiol Infect. 2017 Mar; 23(3):131-140. PMID: 27756712.
    View in: PubMed
  37. Cariem R, Cox V, de Azevedo V, Hughes J, Mohr E, Durán LT, Ndjeka N, Furin J. The experience of bedaquiline implementation at a decentralised clinic in South Africa. Public Health Action. 2016 Sep; 6(3):190-192. PMID: 27695682.
    View in: PubMed
  38. Mafukidze A, Harausz E, Furin J. An update on repurposed medications for the treatment of drug-resistant tuberculosis. Expert Rev Clin Pharmacol. 2016 Jul 18; 1-10. PMID: 27376490.
    View in: PubMed
  39. Koenig SP, Furin J. Update in Tuberculosis/Pulmonary Infections 2015. Am J Respir Crit Care Med. 2016 07 15; 194(2):142-6. PMID: 27420359; PMCID: PMC5003219 [Available on 07/15/17].
  40. Master I, Furin J. Access to new drugs and the global drug-resistant TB crisis: a case series from KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2016 07; 20(7):985-7. PMID: 27287655.
    View in: PubMed
  41. Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges. Eur Respir J. 2016 09; 48(3):938-43. PMID: 27338197.
    View in: PubMed
  42. Kurz SG, Furin JJ, Bark CM. Drug-Resistant Tuberculosis: Challenges and Progress. Infect Dis Clin North Am. 2016 06; 30(2):509-522. PMID: 27208770; PMCID: PMC4876017 [Available on 06/01/17].
  43. Furin J, Cox H. Outbreak of multidrug-resistant tuberculosis on Daru Island. Lancet Respir Med. 2016 05; 4(5):347-9. PMID: 27016866.
    View in: PubMed
  44. Furin J, Brigden G, Lessem E, Rich M, Vaughan L, Lynch S. Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis. Emerg Infect Dis. 2016 Mar; 22(3). PMID: 26885674; PMCID: PMC4766879.
  45. Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P. Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults. Int J Tuberc Lung Dis. 2016 Mar; 20(3):290-4. PMID: 27046707.
    View in: PubMed
  46. Furin J, Isaakidis P. The tuberculosis emergency in eastern Europe. Lancet HIV. 2016 Mar; 3(3):e107-8. PMID: 26939731.
    View in: PubMed
  47. Benbaba S, Isaakidis P, Das M, Jadhav S, Reid T, Furin J. Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO? PLoS One. 2015; 10(12):e0144936. PMID: 26713873; PMCID: PMC4703099.
  48. Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015 Dec; 19 Suppl 1:55-60. PMID: 26564544.
    View in: PubMed
  49. Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK. Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations. Int J Tuberc Lung Dis. 2015 Dec; 19 Suppl 1:61-68. PMID: 26564545.
    View in: PubMed
  50. Furin J, Mafukidze A, Brigden G, du Cros P, Golin R, Harausz E, Seddon JA, Ustero P, Garcia-Prats AJ. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015 Dec 01; 19(12):55-60. PMID: 28871918.
    View in: PubMed
  51. Taneja R, Garcia-Prats AJ, Furin J, Maheshwari HK. Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations. Int J Tuberc Lung Dis. 2015 Dec 01; 19(12):61-68. PMID: 28871919.
    View in: PubMed
  52. Furin J, Akugizibwe P, Ditiu L, Gray G, Palmero D, Zaidi S. No one with HIV should die from tuberculosis. Lancet. 2015 Dec 05; 386(10010):e48-50. PMID: 26515682.
    View in: PubMed
  53. Furin J, Harausz E, Zimetbaum P, Cox H. In reply. QTc prolongation and delamanid: access and safety. Int J Tuberc Lung Dis. 2015 Oct; 19(10):1262-3. PMID: 26459548.
    View in: PubMed
  54. Reed C, Mason L, Cox H, Seaworth B, Lessem E, Furin J. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect Dis. 2015 Oct; 15(10):1131. PMID: 26461942.
    View in: PubMed
  55. Monedero I, Furin J. Programmatic management of children with drug-resistant tuberculosis: common sense and social justice. Public Health Action. 2015 Jun 21; 5(2):92. PMID: 26393107; PMCID: PMC4487481.
  56. Cox HS, Furin JJ, Mitnick CD, Daniels C, Cox V, Goemaere E. The need to accelerate access to new drugs for multidrug-resistant tuberculosis. Bull World Health Organ. 2015 Jul 01; 93(7):491-7. PMID: 26170507; PMCID: PMC4490806.
  57. Furin J. Informed use of bedaquiline for tuberculosis. Lancet. 2015 May 02; 385(9979):1724-1725. PMID: 25943932.
    View in: PubMed
  58. Harausz E, Cox H, Rich M, Mitnick CD, Zimetbaum P, Furin J. QTc prolongation and treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015 Apr; 19(4):385-91. PMID: 25859992.
    View in: PubMed
  59. Brigden G, Furin J, Van Gulik C, Marais B. Getting it right for children: improving tuberculosis treatment access and new treatment options. Expert Rev Anti Infect Ther. 2015 Apr; 13(4):451-61. PMID: 25739933.
    View in: PubMed
  60. Lessem E, Cox H, Daniels C, Furin J, McKenna L, Mitnick CD, Mosidi T, Reed C, Seaworth B, Stillo J, Tisile P, von Delft D. Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives. Int J Infect Dis. 2015 Mar; 32:56-60. PMID: 25809757.
    View in: PubMed
  61. Furin J, Isaakidis P, Reid AJ, Kielmann K. 'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV. Int J Tuberc Lung Dis. 2014 Dec; 18(12):1479-84. PMID: 25517815.
    View in: PubMed
  62. McKenna L, Frick M, Seaworth B, Furin J. The 'invisibility' of children with tuberculosis. J Public Health Policy. 2015 Feb; 36(1):123-5. PMID: 25409704.
    View in: PubMed
  63. Isaakidis P, Smith S, Majumdar S, Furin J, Reid T. Calling tuberculosis a social disease--an excuse for complacency? Lancet. 2014 Sep 20; 384(9948):1095. PMID: 25241715.
    View in: PubMed
  64. Tierney DB, Franke MF, Becerra MC, Alcántara Virú FA, Bonilla CA, Sánchez E, Guerra D, Muñoz M, Llaro K, Palacios E, Mestanza L, Hurtado RM, Furin JJ, Shin S, Mitnick CD. Time to culture conversion and regimen composition in multidrug-resistant tuberculosis treatment. PLoS One. 2014; 9(9):e108035. PMID: 25238411; PMCID: PMC4169600.
  65. Patel N, Furin JJ, Willenberg DJ, Apollon Chirouze NJ, Vernon LT. HIV-related stigma in the dental setting: a qualitative study. Spec Care Dentist. 2015 Jan-Feb; 35(1):22-8. PMID: 25039662; PMCID: PMC4785592.
  66. Jenkins HE, Gegia M, Furin J, Kalandadze I, Nanava U, Chakhaia T, Cohen T. Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011. Euro Surveill. 2014 Mar 20; 19(11). PMID: 24679722.
    View in: PubMed
  67. Isaakidis P, Paryani R, Khan S, Mansoor H, Manglani M, Valiyakath A, Saranchuk P, Furin J. Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. PLoS One. 2013; 8(7):e68869. PMID: 23894358; PMCID: PMC3716893.
  68. Furin J, Brigden G, Lessem E, Becerra MC. Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study. Int J Tuberc Lung Dis. 2013 Sep; 17(9):1239-41. PMID: 23827936.
    View in: PubMed
  69. Gegia M, Jenkins HE, Kalandadze I, Furin J. Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011. Int J Tuberc Lung Dis. 2013 May; 17(5):624-9. PMID: 23575328; PMCID: PMC3734931.
  70. Seddon JA, Perez-Velez CM, Schaaf HS, Furin JJ, Marais BJ, Tebruegge M, Detjen A, Hesseling AC, Shah S, Adams LV, Starke JR, Swaminathan S, Becerra MC. Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children. J Pediatric Infect Dis Soc. 2013 Jun; 2(2):100-9. PMID: 23717785; PMCID: PMC3665326.
  71. Furin J, Mathew T. Tuberculosis control in acute disaster settings: case studies from the 2010 Haiti earthquake. Disaster Med Public Health Prep. 2013 Apr; 7(2):129-30. PMID: 24618162.
    View in: PubMed
  72. Mitnick CD, Franke MF, Rich ML, Alcantara Viru FA, Appleton SC, Atwood SS, Bayona JN, Bonilla CA, Chalco K, Fraser HS, Furin JJ, Guerra D, Hurtado RM, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Seung KJ, Shin SS, Sloutsky A, Tolman AW, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality. PLoS One. 2013; 8(3):e58664. PMID: 23516529; PMCID: PMC3596279.
  73. Franke MF, Appleton SC, Mitnick CD, Furin JJ, Bayona J, Chalco K, Shin S, Murray M, Becerra MC. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis. 2013 Mar; 56(6):770-6. PMID: 23223591; PMCID: PMC3582355.
  74. Lesia N, Miller AC, Rigodon J, Joseph JK, Furin J. Addressing gender inequity in HIV care in rural Lesotho: the 'Male Initiative'. Int Health. 2013 Mar; 5(1):72-7. PMID: 24029849.
    View in: PubMed
  75. Furin J, Miller AC, Lesia N, Cancedda C, Haidar M, Joseph K, Ramanagoaela L, Rigodon J. Gender differences in enrolment in an HIV-treatment programme in rural Lesotho, 2006-2008: a brief report. Int J STD AIDS. 2012 Oct; 23(10):689-91. PMID: 23104741.
    View in: PubMed
  76. Seddon JA, Furin JJ, Gale M, Del Castillo Barrientos H, Hurtado RM, Amanullah F, Ford N, Starke JR, Schaaf HS. Caring for children with drug-resistant tuberculosis: practice-based recommendations. Am J Respir Crit Care Med. 2012 Nov 15; 186(10):953-64. PMID: 22983960.
    View in: PubMed
  77. Drobac PC, Shin SS, Huamani P, Atwood S, Furin J, Franke MF, Lastimoso C, del Castillo H. Risk factors for in-hospital mortality among children with tuberculosis: the 25-year experience in Peru. Pediatrics. 2012 Aug; 130(2):e373-9. PMID: 22826566; PMCID: PMC3408686.
  78. Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, Furin JJ, Shin SS. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. Int J Tuberc Lung Dis. 2012 Jul; 16(7):891-6. PMID: 22507895.
    View in: PubMed
  79. Gegia M, Cohen T, Kalandadze I, Vashakidze L, Furin J. Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis. 2012 Jun; 16(6):812-6. PMID: 22507372; PMCID: PMC3786434.
  80. Keshavjee S, Gelmanova IY, Shin SS, Mishustin SP, Andreev YG, Atwood S, Furin JJ, Miller A. Hepatotoxicity during treatment for multidrug-resistant tuberculosis: occurrence, management and outcome. Int J Tuberc Lung Dis. 2012 May; 16(5):596-603. PMID: 22410436.
    View in: PubMed
  81. Joseph JK, Rigodon J, Cancedda C, Haidar M, Lesia N, Ramanagoela L, Furin J. Lay health workers and HIV care in rural Lesotho: a report from the field. AIDS Patient Care STDS. 2012 Mar; 26(3):141-7. PMID: 22304374.
    View in: PubMed
  82. Jonsson G, Furin J. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? Int J Tuberc Lung Dis. 2012 Jan; 16(1):4-5. PMID: 22236840.
    View in: PubMed
  83. Jonsson G, Furin J. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes? [Perspectives]. Int J Tuberc Lung Dis. 2012 Jan 01; 16(1):4-5. PMID: 29070307.
    View in: PubMed
  84. Jonsson G, Furin J, Jeenah F, Moosa MY, Sivepersad R, Kalafatis F, Schoeman J. Human rights, mental illness, and HIV: the Luthando Neropsychiatric HIV Clinic in Soweto, South Africa. Health Hum Rights. 2011 Dec 15; 13(2):E64-72. PMID: 22773033.
    View in: PubMed
  85. Gegia M, Kalandadze I, Madzgharashvili M, Furin J. Developing a human rights-based program for tuberculosis control in Georgian prisons. Health Hum Rights. 2011 Dec 15; 13(2):E73-81. PMID: 22773034; PMCID: PMC3734935.
  86. Furin J, Gegia M, Mitnick C, Rich M, Shin S, Becerra M, Drobac P, Farmer P, Hurtado R, Joseph JK, Keshavjee S, Kalandadze I. Eliminating the category II retreatment regimen from national tuberculosis programme guidelines: the Georgian experience. Bull World Health Organ. 2012 Jan 01; 90(1):63-6. PMID: 22271966; PMCID: PMC3260578.
  87. Furin J. The role of traditional healers in community-based HIV care in rural Lesotho. J Community Health. 2011 Oct; 36(5):849-56. PMID: 21374087.
    View in: PubMed
  88. Furin J, Haidar M, Lesia N, Ramangoela L, Rigodon J. The role of the nurse in implementation of an HIV treatment program in rural Lesotho. J Assoc Nurses AIDS Care. 2012 Mar-Apr; 23(2):163-9. PMID: 21764607.
    View in: PubMed
  89. Furin J, Bayona J, Becerra M, Farmer P, Golubkov A, Hurtado R, Joseph JK, Keshavjee S, Ponomarenko O, Rich M, Shin S. Programmatic management of multidrug-resistant tuberculosis: models from three countries. Int J Tuberc Lung Dis. 2011 Oct; 15(10):1294-300. PMID: 21669029.
    View in: PubMed
  90. Furin JJ. Blood exposure at the 2010 International Federation of Football Association World Cup: time for universal adaptation of universal precautions. Clin J Sport Med. 2011 May; 21(3):264-5. PMID: 21519297.
    View in: PubMed
  91. Furin J. Improving technical assistance for drug-resistant tuberculosis. Int J Tuberc Lung Dis. 2011 Mar; 15(3):421-2. PMID: 21333116.
    View in: PubMed
  92. Ivers LC, Mukherjee JS, Leandre FR, Rigodon J, Cullen KA, Furin J. South-south collaboration in scale-up of HIV care: building human capacity for care. AIDS. 2010 Jan; 24 Suppl 1:S73-8. PMID: 20023443; PMCID: PMC3169208.
  93. Mathew TA, Shields AL, Imasheva A, Shin SS, Mishustin SP, Peremitin GG, Strelis AK, Yanova GV, Greenfield SF, Furin JJ. Knowledge, attitudes, and practices of physicians in Tomsk Oblast tuberculosis services regarding alcohol use among tuberculosis patients in Tomsk, Russia. Cult Med Psychiatry. 2009 Dec; 33(4):523-37. PMID: 19768525; PMCID: PMC3042364.
  94. Seung KJ, Omatayo DB, Keshavjee S, Furin JJ, Farmer PE, Satti H. Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLoS One. 2009 Sep 25; 4(9):e7186. PMID: 19779624; PMCID: PMC2746313.
  95. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, Pasechnikov AD, Atwood S, Mukherjee JS, Rich ML, Furin JJ, Nardell EA, Kim JY, Shin SS. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008 Oct 18; 372(9647):1403-9. PMID: 18723218.
    View in: PubMed
  96. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Muñoz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008 Aug 07; 359(6):563-74. PMID: 18687637; PMCID: PMC2673722.
  97. Satti H, Seung K, Keshavjee S, Furin J. Extensively drug-resistant tuberculosis, Lesotho. Emerg Infect Dis. 2008 Jun; 14(6):992-3. PMID: 18551748; PMCID: PMC2600315.
  98. Furin J, Shutts M, Keshavjee S. Aviation and the delivery of medical care in remote regions: the Lesotho HIV experience. Aviat Space Environ Med. 2008 Feb; 79(2):136-8. PMID: 18309912.
    View in: PubMed
  99. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis. 2007 Dec; 11(12):1314-20. PMID: 18034952.
    View in: PubMed
  100. Furin JJ, Behforouz HL, Shin SS, Mukherjee JS, Bayona J, Farmer PE, Kim JY, Keshavjee S. Expanding global HIV treatment: case studies from the field. Ann N Y Acad Sci. 2008; 1136:12-20. PMID: 17954668.
    View in: PubMed
  101. Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann N Y Acad Sci. 2008; 1136:1-11. PMID: 17954675.
    View in: PubMed
  102. Furin JJ, Rigodon J, Cancedda C, Keshavjee S, Seung KJ, Letsie M, Kim JY, Joseph JK. Improved case detection of active tuberculosis associated with an antiretroviral treatment program in Lesotho. Int J Tuberc Lung Dis. 2007 Oct; 11(10):1154-6. PMID: 17945074.
    View in: PubMed
  103. Furin J. The clinical management of drug-resistant tuberculosis. Curr Opin Pulm Med. 2007 May; 13(3):212-7. PMID: 17414129.
    View in: PubMed
  104. Chalco K, Wu DY, Mestanza L, Muñoz M, Llaro K, Guerra D, Palacios E, Furin J, Shin S, Sapag R. Nurses as providers of emotional support to patients with MDR-TB. Int Nurs Rev. 2006 Dec; 53(4):253-60. PMID: 17083413.
    View in: PubMed
  105. Somocurcio JG, Sotomayor A, Shin S, Portilla S, Valcarcel M, Guerra D, Furin J. Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru. Thorax. 2007 May; 62(5):416-21. PMID: 16928717; PMCID: PMC2117182.
  106. Drobac PC, Mukherjee JS, Joseph JK, Mitnick C, Furin JJ, del Castillo H, Shin SS, Becerra MC. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006 Jun; 117(6):2022-9. PMID: 16740844.
    View in: PubMed
  107. Shin SS, Furin JJ, Alcántara F, Bayona J, Sánchez E, Mitnick CD. Long-term follow-up for multidrug-resistant tuberculosis. Emerg Infect Dis. 2006 Apr; 12(4):687-8. PMID: 16704823; PMCID: PMC3294679.
  108. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis. 2006 Apr; 10(4):402-8. PMID: 16602404.
    View in: PubMed
  109. Rich ML, Socci AR, Mitnick CD, Nardell EA, Becerra MC, Bonilla C, Bayona J, Seung KJ, Furin J, Farmer PE, Mukherjee JS. Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB. Int J Tuberc Lung Dis. 2006 Mar; 10(3):290-6. PMID: 16562709.
    View in: PubMed
  110. Furin J, Farmer P, Wolf M, Levy B, Judd A, Paternek M, Hurtado R, Katz J. A novel training model to address health problems in poor and underserved populations. J Health Care Poor Underserved. 2006 Feb; 17(1):17-24. PMID: 16520503.
    View in: PubMed
  111. Furin J, Paternek M, Katz JT. Global health equity as the focus of graduate medical education. Med Educ. 2005 Nov; 39(11):1161. PMID: 16262835.
    View in: PubMed
  112. Furin JJ, Johnson JL. Recent advances in the diagnosis and management of tuberculosis. Curr Opin Pulm Med. 2005 May; 11(3):189-94. PMID: 15818178.
    View in: PubMed
  113. Drobac PC, del Castillo H, Sweetland A, Anca G, Joseph JK, Furin J, Shin S. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents. Clin Infect Dis. 2005 Jun 01; 40(11):1689-92. PMID: 15889370.
    View in: PubMed
  114. Furin, J., Walton, D., Farmer, P. . The ever-changing face of AIDS: Implications for patient care. AIDS: Global Policy and Practice. K. Mayer and H. Pizer, eds. 2005; 286-306.
  115. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med. 2004 Oct; 59(7):1529-39. PMID: 15246180.
    View in: PubMed
  116. Seung KJ, Joseph K, Hurtado R, Rich M, Shin S, Furin J, Leandre F, Mukherjee J, Farmer P. Number of drugs to treat multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004 Jun 15; 169(12):1336-7; author reply 1337. PMID: 15187016.
    View in: PubMed
  117. Farmer PE, Furin JJ, Katz JT. Global health equity. Lancet. 2004 May 29; 363(9423):1832. PMID: 15172796.
    View in: PubMed
  118. Shin S, Furin J, Alcántara F, Hyson A, Joseph K, Sánchez E, Rich M. Hypokalemia among patients receiving treatment for multidrug-resistant tuberculosis. Chest. 2004 Mar; 125(3):974-80. PMID: 15006956.
    View in: PubMed
  119. Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 2004 Feb 07; 363(9407):474-81. PMID: 14962530.
    View in: PubMed
  120. Furin, J and Johnson, J. Managing Tuberculosis in the United States: An Update. Resident and Staff Physician. 2004; 50(3):12-21.
  121. Mukherjee JS, Joseph JK, Rich ML, Shin SS, Furin JJ, Seung KJ, Sloutsky A, Socci AR, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru FA, Farmer P, Del Castillo HE. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003 Jul; 7(7):637-44. PMID: 12870684.
    View in: PubMed
  122. Shin S, Guerra D, Rich M, Seung KJ, Mukherjee J, Joseph K, Hurtado R, Alcantara F, Bayona J, Bonilla C, Farmer P, Furin J. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases. Clin Infect Dis. 2003 Apr 15; 36(8):996-1003. PMID: 12684912.
    View in: PubMed
  123. Palacios E, Guerra D, Llaro K, Chalco K, Sapag R, Furin J. The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB). Int J Tuberc Lung Dis. 2003 Apr; 7(4):343-6. PMID: 12729339.
    View in: PubMed
  124. Shin SS, Hyson AM, Castañeda C, Sánchez E, Alcántara F, Mitnick CD, Fawzi MC, Bayona J, Farmer PE, Kim JY, Furin JJ. Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2003 Apr; 7(4):347-53. PMID: 12729340.
    View in: PubMed
  125. Mitnick C, Bayona J, Palacios E, Shin S, Furin J, Alcántara F, Sánchez E, Sarria M, Becerra M, Fawzi MC, Kapiga S, Neuberg D, Maguire JH, Kim JY, Farmer P. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003 Jan 09; 348(2):119-28. PMID: 12519922.
    View in: PubMed
  126. Furin JJ, Mitnick CD, Shin SS, Bayona J, Becerra MC, Singler JM, Alcantara F, Castañieda C, Sanchez E, Acha J, Farmer PE, Kim JY. Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2001 Jul; 5(7):648-55. PMID: 11467371.
    View in: PubMed
  127. Furin JJ, Becerra MC, Shin SS, Kim JY, Bayona J, Farmer PE. Effect of administering short-course, standardized regimens in individuals infected with drug-resistant Mycobacterium tuberculosis strains. Eur J Clin Microbiol Infect Dis. 2000 Feb; 19(2):132-6. PMID: 10746502.
    View in: PubMed
  128. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2000 Feb; 4(2):108-14. PMID: 10694087.
    View in: PubMed
  129. Farmer, PE, Shin, SS, Bayona, J, Kim, JY, Furin, JJ, Brenner, A. . Making DOTS-Plus Work. Multidrug-Resistant Tuberculosis, Bastian,I and Portales, F eds. 2000; 285-302.
  130. Farmer P, Furin J, Bayona J, Becerra M, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis. 1999 Aug; 3(8):643-5. PMID: 10460095.
    View in: PubMed
  131. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, Kim JY, Mitnick C, Nardell E, Shin S. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998 Nov; 2(11):869-76. PMID: 9848606.
    View in: PubMed
  132. Mitnick C, Furin J, Henry C, Ross J. Tuberculosis among the foreign born in Massachusetts, 1982-1994: a reflection of social and economic disadvantage. Int J Tuberc Lung Dis. 1998 Sep; 2(9 Suppl 1):S32-40. PMID: 9755963.
    View in: PubMed
  133. Mitnick C, Furin J, Henry C, Ross J. Tuberculosis among the foreign born in Massachusetts, 1982-1994: a reflection of social and economic disadvantage [The Eddie O'Brien Lecture]. Int J Tuberc Lung Dis. 1998 Sep 01; 2(9):32-40. PMID: 29343325.
    View in: PubMed
  134. Furin JJ. "You have to be your own doctor": sociocultural influences on alternative therapy use among gay men with AIDS in west Hollywood. Med Anthropol Q. 1997 Dec; 11(4):498-504. PMID: 9408903.
    View in: PubMed
  135. Farmer PE and Furin JJ. Sexe, Drogue, et Violences Structurelles: Les Femmes et le V.I.H. Jornal des Anthropologues. 1997; 68-69:35-46.
  136. Farmer, PE, Bayona, J, Becerra, MC, Daily, J, Furin, JJ, et al. . Poverty, Inequality, and Drug Resistance: Meeting Community Needs. Proceedings of the International Union Against Tuberculosis and Lung Disease, North American Regional Conference. 1997; 88-102.
  137. Daily, JP, Farmer PE, Rhatigan J, Katz J, and Furin JJ. Women and HIV Infection. Women, Poverty, and AIDS: Sex, Drugs, and Structural Violence, Farmer PE, Connors MM, and Simmons J, eds. 1996; 125-143.
  138. Korbin, JE, Coulton, CJ, and Furin, JJ. A Neighborhood-Based Approach to Risk Assessment. The APSAC Advisor. 1995; 8(4):9-11.
  139. Liedtke CM, Furin J, Ernsberger P. Alpha 2-adrenergic, but not imidazole, agonists activate NaCl cotransport in rabbit tracheal epithelial cells. Am J Physiol. 1993 Mar; 264(3 Pt 1):C568-76. PMID: 8096363.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Furin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (298)
Explore
_
Co-Authors (35)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_